Cargando…
Hypermethylation of heparanase 2 promotes colorectal cancer proliferation and is associated with poor prognosis
BACKGROUND: The epigenetic abnormality of tumor-associated genes contributes to the pathogenesis of colorectal carcinoma (CRC). However, methylation in colorectal cancer is still poorly characterized. METHOD: By integration of DNA methylation data from the GEO database and gene expression data from...
Autores principales: | Zhang, Hui, Xu, Chenxin, Shi, Chen, Zhang, Junying, Qian, Ting, Wang, Zhuo, Ma, Rong, Wu, Jianzhong, Jiang, Feng, Feng, Jifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934273/ https://www.ncbi.nlm.nih.gov/pubmed/33663522 http://dx.doi.org/10.1186/s12967-021-02770-0 |
Ejemplares similares
-
Allele Loss and Down-Regulation of Heparanase Gene Are Associated with the Progression and Poor Prognosis of Hepatocellular Carcinoma
por: Huang, Guo-Liang, et al.
Publicado: (2012) -
MAPT promoter CpG island hypermethylation is associated with poor prognosis in patients with stage II colorectal cancer
por: Wang, Chuntao, et al.
Publicado: (2019) -
MicroRNAs as biomarkers for the progression and prognosis of colon carcinoma
por: Zhang, Hui, et al.
Publicado: (2018) -
Promoter hypermethylation of LGALS4 correlates with poor prognosis in patients with urothelial carcinoma
por: Wu, Meei-Maan, et al.
Publicado: (2017) -
Hypermethylation of MEG3 promoter correlates with inactivation of MEG3 and poor prognosis in patients with retinoblastoma
por: Gao, Yali, et al.
Publicado: (2017)